Related Experiment Video
Updated: Jun 23, 2026

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Case Report: Voglibose-induced persistent leukopenia in a patient with type 2 diabetes
Jing-Wen Guo1, Jin-Hong Yan2, Li-Shuang Chang3
1Department of Pharmacy, the First Hospital of China Medical University, Shenyang, Liaoning, China.
Long-term use of voglibose, an alpha-glucosidase inhibitor, may rarely cause persistent leukopenia in diabetic patients. Switching to acarbose resolved the condition, suggesting voglibose as the probable cause.
Area of Science:
- Endocrinology
- Hematology
- Pharmacology
Background:
- Alpha-glucosidase inhibitors like voglibose are used to manage type 2 diabetes.
- Hematological adverse effects, including leukopenia, are rare but possible with these medications.
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction